U.S. Sex Reassignment Surgery Market Size, Share & Trends Analysis Report By Gender Transition (Male To Female, Female To Male), And Segment- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The U.S. sex reassignment surgery market size was estimated at USD 2.89 billion in 2022 and is expected to surpass around USD 8.39 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 11.24% during the forecast period 2023 to 2032.

Key Takeaways:

• By Gender Transition the U.S. Sex Reassignment Surgery market was valued at USD 2.89 billion in 2022 and expected to witness growth at a CAGR of 11.2% from 2023 to 2032.
• By gender transition, the female-to-male segment held the largest revenue share in 2022. Demand for sex reassignment surgery is increasing due to an increase in the number of people opting for sex-change surgeries and growing awareness and acceptance of the transgender community
• According to the 2020 plastic surgery statistics by the American Society of Plastic Surgeons, breast or chest surgeries are major contributors to the growth of the female-to-male segment
• The increasing number of sex reassignment surgeries is among the major factors driving the growth of the sex reassignment surgery market. Rise is seen among the patients choosing to change their sex from female to male and male to female, which has increased nearly four times ever since the last decade
• The male-to-female transition surgery is expected to witness the fastest growth during the forecast period owing to the high prevalence of gender dysphoria among males
• The companies operating in the market are engaging in new facility launches to strengthen their market presence. For instance, in September 2020, seven hospital facilities within the Mount Sinai Health System have been recognized as national leaders in LGBTQ health care equality by the Human Rights Campaign Foundation's 2020 Healthcare Equality Index (HEI)

U.S. Sex Reassignment Surgery Market Report Scope

The rising incidences of gender dysphoria and the increasing number of people opting for gender confirmation surgeries are expected to boost the growth during the forecast period. According to a study conducted by Cedars Sinai in June 2020, approximately 78% of transgender males experienced gender dysphoria by the age of 7. The mean age to experience gender dysphoria was less in transgender males, which is about 6.2 years.

Sex reassignment surgery is gaining popularity among the young transgender population in the U.S., as it helps people with gender dysphoria transition to their self-identified gender. According to an article published in the New York Times, around 1.4% & 1.3% of young people aged 13 to 17 and 18 to 24, respectively, are transgender in the U.S., accounting for only 0.5% of total adults.

The increasing number of sex reassignment surgeries in the U.S. is expected to propel the growth of the industry during the forecast period. According to the 2020 Plastic Surgery Statistics by the American Society of Plastic Surgeons (ASPS), a 15% rise in breast or chest surgical procedures was reported in transgender male patients from 2019 to 2020.

The improving reimbursement scenario is also anticipated to positively impact the market growth during the forecast period. Insurance providers such as Aetna and Unicare provide insurance for necessary surgical procedures, such as salpingo-oophorectomy, hysterectomy, orchiectomy, or ovariectomy. In the U.S., around 152,000 transgender individuals are enrolled in Medicaid and only 69,000 among them have access to gender-affirming care coverage under state law.

The pandemic impacted the financial status of transgender individuals as the unemployment rate among transgender people was high due to the pandemic. This has led to a decline in the number of gender-affirming surgeries in the U.S. as the procedures are costlier and many states do not provide any coverage for the surgeries. For instance, Human Rights Campaign Foundation conducted a poll of 7,000 participants from the LGBTQ community in the U.S. and found that around 26% of transgender people of color and around 19% of transgender people were unemployed from April 2020 to May 2020.

Gender Transition Insights

Based on gender transition, the market is segmented into male-to-female (MTF) and female-to-male (FTM). The FTM segment dominated the market in 2022 with the largest revenue share. This is attributed to continuous innovations in metoidioplasty, phalloplasty, scrotoplasty, and chest reconstructing. According to ASPS, there was an overall 14% & 15% increase in transgender female sex reassignment surgeries and breast/chest & facial procedures in 2022, respectively.

The MTF sex reassignment surgery is expected to witness the fastest growth during the forecast period owing to the high prevalence of gender dysphoria among males compared to females. According to the 2021 annual report of the Mount Sinai Center for Transgender Medicine and Surgery, around 861 gender-affirming surgeries were performed at this hospital, wherein 639 surgeries were feminization procedures. The transmasculine population aged 25 to 34 is more likely to undergo gender-affirming surgeries, accounting for around 43% of total transfeminine surgeries.

In addition, according to the American Society of Plastic Surgeons, transgender males in the U.S. underwent 9,985 gender confirmation surgeries in 2023 compared to 8,986 in 2022. Government support is also driving the market. Thus, government support in the form of Medicare coverage and an increase in the number of gender confirmation surgeries are factors likely to boost the market growth.

Key Companies & Market Share Insights

The U.S. sex reassignment surgery market is fragmented. The companies contributing to the market growth are focusing on adopting several strategies to strengthen their market presence. They are offering advanced and innovative surgical solutions, including tracheal shave (chondrolaryngoplasty), male & female breast reduction, neo-vaginoplasty, and genital remodeling. Companies are investing in LGBTQ+ healthcare and are accredited on Health Care Equality Index. For instance, in September 2020, Cedars Sinai achieved a score of 100 on the Human Rights Campaign Foundation's 2020 Health Care Equality Index. Some prominent players in the U.S. sex reassignment surgery market include:

• The Mount Sinai Health System
• Transgender Surgery Institute of Southern California
• Cedars Sinai
• Moein Surgical Arts
• Boston Medical Center
• Cleveland Clinic
• CNY Cosmetic & Reconstructive Surgery
• Plastic Surgery Group Rochester
• The University of Michigan Health System
• The Johns Hopkins University

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the U.S. Sex Reassignment Surgery market.

By Gender Transition 

• Male-To-Female
• Female-To-Male